Insertable cardiac monitors: current indications and devices

References

• Brignole M, Moya A, de Lange FJ, et al. ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948.
   Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Circulation. 2018;138(13):e272-e391.
   Google Scholar
• Linker NJ, Voulgaraki D, Garutti C, et al. Early versus delayed implantation of a loop recorder in patients with unexplained syncope–effects on care pathway and diagnostic yield. Int J Cardiol. 2013;170(2):146–151.
   PubMed Web of Science ®Google Scholar
• Lacunza-Ruiz FJ, Moya-Mitjans A, Martinez-Alday J, et al. Implantable loop recorder allows an etiologic diagnosis in one-third of patients. Results of the Spanish reveal registry. Circ J. 2013;77(10):2535–2541.
   PubMed Web of Science ®Google Scholar
• Moya A, Garcia-Civera R, Croci F, et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011;32(12):1535–1541.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Klein GJ, Norris C, et al. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995;92(7):1819–1824.
   PubMed Web of Science ®Google Scholar
• Brignole M, Arabia F, Ammirati F, et al. Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the syncope unit project 2 (SUP 2) study. Europace. 2016;18(9):1427–1433.
   PubMed Web of Science ®Google Scholar
• Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third international study on syncope of uncertain etiology (ISSUE-3): a randomized trial. Circulation. 2012;125(21):2566–2571.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Klein GJ, Yee R, et al. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation. 1999;99(3):406–410.
   PubMed Web of Science ®Google Scholar
• Solbiati M, Costantino G, Casazza G, et al. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database Syst Rev. 2016;4:CD011637.
   PubMed Web of Science ®Google Scholar
• Volosin K, Stadler RW, Wyszynski R, et al. Tachycardia detection performance of implantable loop recorders: results from a large ‘real-life’ patient cohort and patients with induced ventricular arrhythmias. Europace. 2013;15(8):1215–1222.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–2477.
   PubMed Web of Science ®Google Scholar
• Ganzeboom KS, Mairuhu G, Reitsma JB, et al. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol. 2006;17(11):1172–1176.
   PubMed Web of Science ®Google Scholar
• Kapoor WN. Evaluation and management of the patient with syncope. JAMA. 1992;268(18):2553–2560.
   PubMed Web of Science ®Google Scholar
• Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878–885.
   PubMed Web of Science ®Google Scholar
• Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. 2011;13(2):262–269.
   PubMed Web of Science ®Google Scholar
• Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104(11):1261–1267.
   PubMed Web of Science ®Google Scholar
• Brignole M, Menozzi C, Moya A, et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001;104(17):2045–2050.
   PubMed Web of Science ®Google Scholar
• Menozzi C, Brignole M, Garcia-Civera R, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105(23):2741–2745.
   PubMed Web of Science ®Google Scholar
• Da Costa A, Defaye P, Romeyer-Bouchard C, et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. Arch Cardiovasc Dis. 2013;106(3):146–154.
   PubMed Web of Science ®Google Scholar
• Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J. 2006;27(3):351–356.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Klein GJ, Yee R, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104(1):46–51.
   PubMed Web of Science ®Google Scholar
• Podoleanu C, DaCosta A, Defaye P, et al. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study). Arch Cardiovasc Dis. 2014;107(10):546–552.
   PubMed Web of Science ®Google Scholar
• Sulke N, Sugihara C, Hong P, et al. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial. Europace. 2016;18(6):912–918.
   PubMed Web of Science ®Google Scholar
• Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006;27:1085–1092.
   PubMed Web of Science ®Google Scholar
• Giustetto C, Cerrato N, Ruffino E, et al. Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope. Int J Cardiol. 2017;241:188–193.
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp LR, Vink AS, Wilde AA, et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes. Heart Rhythm. 2015;12(2):367–375.
   PubMed Web of Science ®Google Scholar
• Sakhi R, Theuns DA, Bhagwandien RE, et al. Value of implantable loop recorders in patients with structural or electrical heart disease. J Interv Card Electrophysiol. 2018;52(2):203–208.
   PubMed Web of Science ®Google Scholar
• Champagne J, Philippon F, Gilbert M, et al. The Brugada syndrome in Canada: a unique French-Canadian experience. Can J Cardiol. 2007;23(Suppl B):71B–5B.
   PubMedGoogle Scholar
• Kubala M, Aissou L, Traulle S, et al. Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia. Europace. 2012;14(6):898–902.
   PubMed Web of Science ®Google Scholar
• Sacher F, Arsac F, Wilton SB, et al. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm. 2012;9(8):1272–1279.
   PubMed Web of Science ®Google Scholar
• Avari Silva JN, Bromberg BI, Emge FK, et al. Implantable loop recorder monitoring for refining management of children with inherited arrhythmia syndromes. J Am Heart Assoc. 2016;5:6.
   Web of Science ®Google Scholar
• Frangini PA, Cecchin F, Jordao L, et al. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008;31(3):338–343.
   PubMed Web of Science ®Google Scholar
• Stollberger C, Keller H, Steger C, et al. Implantable loop-recorders in myopathic and non-myopathic patients with left ventricular hypertrabeculation/noncompaction. Int J Cardiol. 2013;163(2):146–148.
   PubMed Web of Science ®Google Scholar
• Weidemann F, Maier SK, Stork S, et al. Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced fabry cardiomyopathy. Am J Cardiol. 2016;118(2):264–274.
   PubMed Web of Science ®Google Scholar
• Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J. 2014;35(39):2733–2779.
   PubMed Web of Science ®Google Scholar
• Antzelevitch C, Yan GX, Ackerman MJ, et al. J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm. 2016;13(10):e295–324.
   PubMed Web of Science ®Google Scholar
• Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481–2488.
   PubMed Web of Science ®Google Scholar
• Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361(15):1427–1436.
   PubMed Web of Science ®Google Scholar
• Bloch Thomsen PE, Jons C, Raatikainen MJ, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the cardiac arrhythmias and risk stratification after acute myocardial infarction (CARISMA) study. Circulation. 2010;122:1258–1264.
   PubMed Web of Science ®Google Scholar
• Gang UJ, Jons C, Jorgensen RM, et al. Heart rhythm at the time of death documented by an implantable loop recorder. Europace. 2010;12(2):254–260.
   PubMed Web of Science ®Google Scholar
• Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol. 2000;36(1):181–184.
   PubMed Web of Science ®Google Scholar
• Petkar S, Hamid T, Iddon P, et al. Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy–REVISE study. Europace. 2012;14(11):1653–1660.
   PubMed Web of Science ®Google Scholar
• Ho RT, Wicks T, Wyeth D, et al. Generalized tonic-clonic seizures detected by implantable loop recorder devices: diagnosing more than cardiac arrhythmias. Heart Rhythm. 2006;3(7):857–861.
   PubMed Web of Science ®Google Scholar
• Maggi R, Rafanelli M, Ceccofiglio A, et al. Additional diagnostic value of implantable loop recorder in patients with initial diagnosis of real or apparent transient loss of consciousness of uncertain origin. Europace. 2014;16(8):1226–1230.
   PubMed Web of Science ®Google Scholar
• Kanjwal K, Karabin B, Kanjwal Y, et al. Differentiation of convulsive syncope from epilepsy with an implantable loop recorder. Int J Med Sci. 2009;6(6):296–300.
   PubMed Web of Science ®Google Scholar
• Simpson CS, Barlow MA, Krahn AD, et al. Recurrent seizure diagnosed by the insertable loop recorder. J Interv Card Electrophysiol. 2000;4(3):475–479.
   PubMed Web of Science ®Google Scholar
• Bhangu J, Hall P, Devaney N, et al. The prevalence of unexplained falls and syncope in older adults presenting to an Irish urban emergency department. Eur J Emerg Med. 2018 Feb 20. doi:10.1097/MEJ.0000000000000548.
   PubMedGoogle Scholar
• Bhangu J, McMahon CG, Hall P, et al. Long-term cardiac monitoring in older adults with unexplained falls and syncope. Heart. 2016;102:681–686.
   PubMed Web of Science ®Google Scholar
• Armstrong VL, Lawson J, Kamper AM, et al. The use of an implantable loop recorder in the investigation of unexplained syncope in older people. Age Ageing. 2003;32(2):185–188.
   PubMed Web of Science ®Google Scholar
• Ryan DJ, Nick S, Colette SM, et al. Carotid sinus syndrome, should we pace? A multicentre, randomised control trial (Safepace 2). Heart. 2010;96(5):347–351.
   PubMed Web of Science ®Google Scholar
• Giada F, Gulizia M, Francese M, et al. Recurrent unexplained palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol. 2007;49(19):1951–1956.
   PubMed Web of Science ®Google Scholar
• Brignole M, Vardas P, Hoffman E, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11(5):671–687.
   PubMed Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR,et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–129.
   PubMedGoogle Scholar
• Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478–2486.
   PubMed Web of Science ®Google Scholar
• Ziegler PD, Rogers JD, Ferreira SW, et al. Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. Int J Cardiol. 2017;244:175–179.
   PubMed Web of Science ®Google Scholar
• Diamantopoulos A, Sawyer LM, Lip GY, et al. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. Int J Stroke. 2016;11(3):302–312.
   PubMed Web of Science ®Google Scholar
• Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191–2201.
   PubMed Web of Science ®Google Scholar
• Diener HC, Easton JD, Granger CB, et al. Design of randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of the oral thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT ESUS). Int J Stroke. 2015;10(8):1309–1312.
   PubMed Web of Science ®Google Scholar
• Verma N, Ziegler PD, Liu S, et al. Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: insights from insertable cardiac monitors. Int J Stroke. 2018 Sep 10. Doi:10.1177/1747493018798554.
   Google Scholar
• Columbia University. AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke (ARCADIA). ClinicalTrials.gov [Internet]. NLM Identifier: NLM Identifier: NCT03192215. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2018 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT03192215
   Google Scholar
• University Hospital Tuebingen. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS). ClinicalTrials.gov [Internet]. NLM Identifier: NLM Identifier: NCT02427126. Bethesda (MD): National Library of Medicine (US). 2000. [cited 2018 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT02427126
   Google Scholar
• Healey JS, Alings M, Ha A, et al. Subclinical atrial fibrillation in older patients. Circulation. 2017;136(14):1276–1283.
   PubMed Web of Science ®Google Scholar
• Nasir JM, Pomeroy W, Marler A, et al. Predicting determinants of atrial fibrillation or flutter for therapy elucidation in patients at risk for thromboembolic events (PREDATE AF) study. Heart Rhythm. 2017;14(7):955–961.
   PubMed Web of Science ®Google Scholar
• Reiffel JA, Verma A, Kowey PR, et al. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study. JAMA Cardiol. 2017;2(10):1120–1127.
   PubMed Web of Science ®Google Scholar
• Diederichsen SZ, Haugan KJ, Kober L, et al. Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): rationale and design of a large randomized controlled trial. Am Heart J. 2017;187:122–132.
   PubMed Web of Science ®Google Scholar
• Rigshospitalet. Atrial fibrillation detected by continuous ECG monitoring (LOOP). ClinicalTrials.gov [Internet]. NLM Identifier: NLM Identifier: NCT02036450. Bethesda (MD): National Library of Medicine (US). 2000. [cited 2018 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT02036450
   Google Scholar
• Lopes RD, Alings M, Connolly SJ, et al. Rationale and design of the apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA) trial. Am Heart J. 2017;189:137–145.
   PubMed Web of Science ®Google Scholar
• Population Health Research Institute. Apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA). ClinicalTrials.gov [Internet]. NLM Identifier: NLM Identifier: NCT01938248. Bethesda (MD): National Library of Medicine (US). 2000. [cited 2018 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT01938248
   Google Scholar
• Kirchhof P, Blank BF, Calvert M, et al. Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017;190:12–18.
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Network. Non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH). ClinicalTrials.gov [Internet]. NLM Identifier: NLM Identifier: NCT02618577. Bethesda (MD): National Library of Medicine (US). 2000. [cited 2018 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT02618577
   Google Scholar
• Gersak B, Pernat A, Robic B, et al. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(10):1059–1066.
   PubMed Web of Science ®Google Scholar
• Pokushalov E, Romanov A, Corbucci G, et al. Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring. J Cardiovasc Electrophysiol. 2011;22(4):369–375.
   PubMed Web of Science ®Google Scholar
• Hanke T, Charitos EI, Stierle U, et al. Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation. 2009;120(11 Suppl):S177–84.
   PubMed Web of Science ®Google Scholar
• Pecha S, Aydin MA, Ahmadzade T, et al. Implantable loop recorder monitoring after concomitant surgical ablation for atrial fibrillation (AF): insights from more than 200 continuously monitored patients. Heart Vessels. 2016;31(8):1347–1353.
   PubMed Web of Science ®Google Scholar
• Perez-Castellano N, Fernandez-Cavazos R, Moreno J, et al. The COR trial: a randomized study with continuous rhythm monitoring to compare the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation. Heart Rhythm. 2014;11(1):8–14.
   PubMed Web of Science ®Google Scholar
• Kapa S, Epstein AE, Callans DJ, et al. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. J Cardiovasc Electrophysiol. 2013;24(8):875–881.
   PubMed Web of Science ®Google Scholar
• Pokushalov E, Romanov A, Corbucci G, et al. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study. Circ Arrhythm Electrophysiol. 2011;4(6):823–831.
   PubMed Web of Science ®Google Scholar
• Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160.
   PubMed Web of Science ®Google Scholar
• Zuern CS, Kilias A, Berlitz P, et al. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors. Pacing Clin Electrophysiol. 2015;38(6):688–693.
   PubMed Web of Science ®Google Scholar
• Passman R, Leong-Sit P, Andrei AC, et al. Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the rhythm evaluation for anticoagulation with continuous monitoring (REACT.COM) pilot study. J Cardiovasc Electrophysiol. 2016;27(3):264–270.
   PubMed Web of Science ®Google Scholar
• Purerfellner H, Sanders P, Pokushalov E, et al. Miniaturized Reveal LINQ insertable cardiac monitoring system: first-in-human experience. Heart Rhythm. 2015;12(6):1113–1119.
   PubMed Web of Science ®Google Scholar
• Ooi SY, Ng B, Singarayar S, et al. BioMonitor 2 pilot study: early experience with implantation of the biotronik biomonitor 2 implantable cardiac monitor. Heart Lung Circ. 2018;27(12):1462-1466.
   PubMed Web of Science ®Google Scholar
• Bisignani G, De Bonis S, Bisignani A, et al. Sensing performance, safety, and patient acceptability of long-dipole cardiac monitor: an innovative axillary insertion. Pacing Clin Electrophysiol. 2018;41(3):277–283.
   PubMed Web of Science ®Google Scholar
• Lacour P, Dang PL, Huemer M, et al. Performance of the new biomonitor 2-AF insertable cardiac monitoring system: can better be worse? Pacing Clin Electrophysiol. 2017;40(5):516–526.
   PubMed Web of Science ®Google Scholar
• Purerfellner H, Pokushalov E, Sarkar S, et al. P-wave evidence as a method for improving algorithm to detect atrial fibrillation in insertable cardiac monitors. Heart Rhythm. 2014;11(9):1575–1583.
   PubMed Web of Science ®Google Scholar
• Mittal S, Rogers J, Sarkar S, et al. Real-world performance of an enhanced atrial fibrillation detection algorithm in an insertable cardiac monitor. Heart Rhythm. 2016;13(8):1624–1630.
   PubMed Web of Science ®Google Scholar
• Noelker G, Busch M, Schmitt J, et al. The BioMonitor 2 master study: early experience with a new insertable cardiac monitor. Circulation. 2018;136:A16347.
   Web of Science ®Google Scholar
• Passman RS, Rogers JD, Sarkar S, et al. Development and validation of a dual sensing scheme to improve accuracy of bradycardia and pause detection in an insertable cardiac monitor. Heart Rhythm. 2017;14(7):1016–1023.
   PubMed Web of Science ®Google Scholar
• Steffel J, Wright DJ, Schafer H, et al. Insertion of miniaturized cardiac monitors outside the catheter operating room: experience and practical advice. Europace. 2017;19(10):1624–1629.
   PubMed Web of Science ®Google Scholar
• Kanters TA, Wolff C, Boyson D, et al. Cost comparison of two implantable cardiac monitors in two different settings: reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room. Europace. 2016;18(6):919–924.
   PubMed Web of Science ®Google Scholar
• Rogers JD, Sanders P, Piorkowski C, et al. In-office insertion of a miniaturized insertable cardiac monitor: results from the Reveal LINQ In-Office 2 randomized study. Heart Rhythm. 2017;14(2):218–224.
   PubMed Web of Science ®Google Scholar
• Furukawa T, Maggi R, Bertolone C, et al. Effectiveness of remote monitoring in the management of syncope and palpitations. Europace. 2011;13(3):431–437.
   PubMed Web of Science ®Google Scholar
• Ciconte G, Vicedomini G, Giacopelli D, et al. Feasibility of remote monitoring using a novel long-dipole insertable cardiac monitor. JACC Clin Electrophysiol. 2018;4(4):559–561.
   PubMedGoogle Scholar
• Cheung CC, Krahn AD, Andrade JG. The emerging role of wearable technologies in detection of arrhythmia. Can J Cardiol. 2018;34(8):1083–1087.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–666.
   PubMed Web of Science ®Google Scholar
• Boehmer JP, Hariharan R, Devecchi FG, et al. A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017;5(3):216–225.
   PubMed Web of Science ®Google Scholar
• Medtronic Cardiac Rhythm and Heart Failure. Reveal LINQ™ Heart Failure (LINQ HF). ClinicalTrials.gov [Internet]. NLM Identifier: NLM Identifier: NCT02758301. Bethesda (MD): National Library of Medicine (US). 2000. [cited 2018 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT02758301
   Google Scholar